| Primary information |
|---|
| ID | antitb_1547 |
| Peptide Name | Lassomycin |
| Sequence | GLRRLFADQLVGRRN |
| N-terminal Modification | Free |
| C-terminal Modification | Methylation |
| Chemical Modification | Free NH- group of first Glycine form NHCO bond with CO group of eight Asparagine to form cyclic bond |
| Linear/ Cyclic | Cyclic |
| Length | 15 |
| Chirality | D |
| Nature | Cationic |
| Source | Natural |
| Origin | Derived from lentzea kentuckyensis |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis MDR |
| Inhibition Concentartion | IC50= 0.8-3 mg/ml |
| In vitro/In vivo | in vitro |
| Cell Line | NA |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 25613372 |
| Year of Publication | 2015 |
| 3-D Structure | NA |